SCHEMBL9301793

SCHEMBL9301793

CCC(c1ccccc1)N1CCNCCNCCN(CC(=O)O)CC1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 10/20 0.53
▸ SLC6A2 P23975 9/20 0.53
▸ OPRD1 P41143 4/20 0.48
▸ TACR1 P25103 3/20 0.47
▸ SLC6A3 Q01959 3/20 0.47
▸ KCNH2 Q12809 2/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ CACNA1F O60840 1/20 0.46
▸ CACNA1D Q01668 1/20 0.46
▸ CACNA1S Q13698 1/20 0.46
▸ CACNA1C Q13936 1/20 0.46
▸ OPRM1 P35372 2/20 0.45
▸ OPRK1 P41145 1/20 0.45
▸ OPRL1 P41146 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3268419 0.83 SLC6A4 (0.68) SLC6A4SLC6A2OPRD1SLC6A3KCNH2
SCHEMBL29092017 0.78 SIGMAR1 (0.46) OPRD1TACR1
SCHEMBL3246700 0.77 SLC6A4 (0.63) SLC6A4SLC6A2SLC6A3KCNH2CYP3A4
SCHEMBL2962625 0.75 OPRM1 (0.65) SLC6A4SLC6A2OPRD1SLC6A3KCNH2
SCHEMBL28187151 0.74 SLC6A4 (0.56) SLC6A4SLC6A2OPRD1SLC6A3KCNH2
SCHEMBL5550813 0.73 CHRM5 (0.48) —
SCHEMBL1691475 0.72 SLC6A9 (0.74) OPRD1CACNA1COPRM1
SCHEMBL13185789 0.72 SIGMAR1 (0.72) KCNH2CYP3A4CYP2D6
SCHEMBL5556374 0.72 CHRM5 (0.47) —
SCHEMBL472213 0.72 CHRM5 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994006805-A1 BORON-GADOLINIUM COMPOUNDS AND METHOD OF CONDUCTING IMAGING AND/OR NEUTRON CAPTURE THERAPY WITH SAME BORON BIOLOGICALS, INCORPORATED (US) 1994-03-31 — — WO disclosed
US-5286853-A Boron-gadolinium compounds and method of conducting imaging and/or neutron capture therapy with same BORON BIOLOGICALS, INC. (US) 1994-02-15 — — US disclosed
Send feedback